Introduction {#sec1}
============

Epilepsy is one of the most common chronic neurological disorders in the world, and the mean prevalence rate of active epilepsy was 8% worldwide \[[@cit0001]--[@cit0005]\]. A higher prevalence of epilepsy was estimated in developing countries (10--40) \[[@cit0006]--[@cit0008]\], as compared to developed countries (4.9%) \[[@cit0009]\]. Epilepsy prevalence might be associated with population demographics, sex, socioeconomic status and methodology of studies, with higher prevalence determined in males and people in the lower socioeconomic groups \[[@cit0009]\]. Furthermore, it is reported to be linked to poor academic achievement, low income and unemployment.

Many abnormalities of the nervous system can result in seizure activity such as brain tumors. Seizures can also occur in the normal nervous system when its metabolic balance is disturbed. The cause (etiology) of epilepsy may not be clearly known (idiopathic) or related to a particular disease state \[[@cit0010]\]. Schaller revealed that the pathophysiological modifications related to epileptic activity in peri- and intra-tumoral tissue are complex \[[@cit0011]\], and stated that the pathophysiological basis of seizures associated with brain tumors is related to different biochemical, anatomical and physiological changes \[[@cit0011]\].

Comprehensive information about epilepsy can help us in coping successfully with this situation by its management and epilepsy control. At present, epidemiologic data concerning the burden and etiology of epilepsy in different regions of Iran are scarce. Moreover, levels of suitable knowledge about epilepsy vary by country and are fewer in developing countries when compared with developed centuries because of the educational program. It was estimated that 4.7 million people suffer from epilepsy in nine countries of the Mediterranean region \[[@cit0012], [@cit0013]\]. Despite the benefits of control programs, they are not readily conduct in treatment centers due to a lack of consolidated reports in Iran. In this review, we systematically reviewed evidence-based determinants of health-related quality of life (QOL), sociodemographic factors (age, sex, etc.), residential areas, general attitudes toward epilepsy, socioeconomic domains, prevalence and incidence in different people with epilepsy (PWE) living in Iran.

Material and methods {#sec2}
====================

The Google search was performed principally and then the reference lists of relevant articles were searched in major electronic databases on patients with epilepsy including PubMed, ScienceDirect, Web of Science, Scopus, ISC, Iran Doc etc, and favoring publications with an English abstract, although a number of Persian sources were also included in this study. No restrictions were made pertaining to the time of available studies. The literature was chosen to reflect the study's focus on epilepsy: adolescents, children socioeconomic status, attitudes toward epilepsy, and the quality of life of patients with epilepsy. We screened the abstracts and full text of available articles. The following methodological data were considered for each relevant article: country of origin; study aim/objective and study design. Then, eligible studies were chosen for inclusion. In addition, all modifications have been shown on the human epileptic brain in a schematic image ([Figure 1](#f0001){ref-type="fig"}).

![Graphic abstract: Schematic image shows the different types of brain changes (**A--D**) in epilepsy as a neurological disorder caused by unusual nerve cell activity in the brain](AMS-14-27701-g001){#f0001}

Results {#sec3}
=======

Prevalence and incidence of epilepsy in Iran {#sec3.1}
--------------------------------------------

Previous studies on epilepsy were included in this review ([Tables I](#t0001){ref-type="table"} and [II](#t0002){ref-type="table"}). According to the Iranian Epilepsy Association, about 80,000 epileptic patients registered in Iran until the end of 2007. The point prevalence of epilepsy has been estimated to be between 2.1 and 4 per 1000 individuals in Iran \[[@cit0014]\]. A previous study indicated that prevalence of epilepsy increased from 2 to 34 per 10 000 individuals during the period of 1970 to 2000 in mentally retarded students, Tehran. Moreover, the prevalence of epilepsy in the study population was calculated a 10.55% among the retarded children in 2002 \[[@cit0015]\].

###### 

Demographic characteristics and prevalence of epilepsy patients by sex and age group in different regions of Iran

  Demographic variable                          Results                                         Reference
  --------------------------------------------- ----------------------------------------------- --------------------------------------
  Gender, mean ± standard:                                                                      Riasi *et al.*, 2015 \[[@cit0055]\]
   Male                                         27.44 ±6.57                                     
   Female                                       27.93 ±7.76                                     
  Age group (M/F), *n* (%) \[years\]:                                                           
   18--20                                       43 (24.0)/65 (33.3)                             
   21--30                                       72 (40.2)/41 (21.1)                             
   31--40                                       64 (35.8)/89 (45.6)                             
  Age group, *n* (%) and SD of M/F \[years\]:   Ebrahimi *et al.*, 2012 \[[@cit0056]\]          
   ≤ 9                                          3 (25.2) (17.66--27.74)/3 (29.7) (24.4--35.0)   
   10--19                                       2 (11.8) (9.7--13.9)/1 (5.6) (4.4--6.8)         
   20--29                                       0/4 (10.4) (6.6--14.1)                          
   30--39                                       2 (7.2) (5.1--9.3)/0                            
   40--49                                       2 (14.5) (12.4--16.6)/2 (14.5) (12.4--16.6)     
   50--59                                       1 (5.9) (5.5--6.3)/0                            
   60--69                                       1 (6.7) (6.1--7.3)/0                            
   ≥ 70                                         1 (15.9) (10.7--21.1)/1 (12.8) (7.6--17.9)      
  Sex:                                          No (%) of M/F                                   Talebi *et al.*, 2013 \[[@cit0057]\]
   Male                                         5 (0/274)                                       
   Female                                       3 (0/131)                                       
  Age group, *n* (%) \[years\]:                                                                 
   ≤ 9                                          13.34                                           
   10--19                                       18.05                                           
   20--29                                       23.70                                           
   30--39                                       16.33                                           
   40--49                                       12.48                                           
   50--59                                       7.74                                            
   60--69                                       4.47                                            
   70--79                                       2.91                                            
   ≥ 80                                         0.98                                            
  Gender, *n* (%):                              Zibaei *et al.*, 2011 \[[@cit0058]\]            
   Male                                         55 (64.7)                                       
   Female                                       30 (35.3)                                       
  Age group, *n* (%) \[years\]:                                                                 
   1--19                                        42 (49.4)                                       
   20--39                                       28 (32.9)                                       
   40--59                                       12 (14.1)                                       
   ≥ 60                                         3 (3.5)                                         
  Gender, *n* (%) \[years\]:                    Asadi-Pooya *et al.*, 2012 \[[@cit0059]\]       
   Male                                         142 (53.8)                                      
   Female                                       122 (46.2)                                      
  Age, mean ± SD \[years\]                      28.7 ±10.5                                      
  Gender, *n* (%) \[years\]:                    Rezaei and Saeidi, 2000 \[[@cit0060]\]          
   Male                                         177 (61)                                        
   Female                                       113 (39)                                        
  Age group, *n* (%) \[years\]:                                                                 
   0--2                                         14 (4.8)                                        
   2--10                                        80 (27.6)                                       
   11--20                                       94 (32.4)                                       
   21--30                                       44 (15.2)                                       
   31--40                                       34 (11.7)                                       
   41--50                                       6 (2.1)                                         
   51--60                                       9 (3.1)                                         
   61--70                                       3 (1)                                           
   71--80                                       6 (2.1)                                         

*M -- male, F -- female.*

###### 

Classification on the prevalence of epileptic patients in various regions of Iran

  Study location (city)   Study period   No. of patients   Prevalence (%) per 1000 persons
  ----------------------- -------------- ----------------- ---------------------------------
  Tehran                  2002           4361              105.6
  Tehran                  2005           50                50
  Tehran                  2005           113               70
  Tehran                  2006           454               18
  Qom                     1998 to 2007   466               31
  Khorasan                2008           369               81
  Esfahan                 2010           101               59
  Birjand                 2010           2085              9
  Yazd                    2010           40                57
  Mazandaran              2010           150               10
  Kermanshah              1994 to 2010   391               51.2
  Kerman                  2010 to 2011   23                7.87
  Shiraz                  2008 to 2011   2190              20.2
  Shiraz                  2008 to 2013   239               8.7

Noorbala *et al.* \[[@cit0016]\] reported that epilepsy prevalence was 1.2% (crude prevalence per 1000 population) in 2004 in Iran.

A cross-sectional nationwide epidemiological study of the Iranian population was conducted by Mohammadi *et al.* \[[@cit0017]\] in 2001. They estimated that the prevalence of epilepsy was 1.8%. The prevalence of seizures was about 0.95% in primary school children in Tabriz (9/56 per 1000 individuals) \[[@cit0018]\], and the prevalence of epilepsy was estimated as about 0.9% at primary schools of Birjand, South Khorasan Province, in 2010.

Furthermore, considering the existing data, it has been estimated that the pooled prevalence of epilepsy is about 5% in Iran, 5% in central Iran, 1% in northern parts and 4% in eastern Iran \[[@cit0019]\], while its prevalence and incidence in different regions of Iran were given uncertain status awaiting further data. It is believed that further epidemiologic data are required for interpretation of the disease status, and the prevalence and incidence of epilepsy in Iran are now difficult to interpret without comprehensive epidemiological data. There is no available information to estimate the incidence of epilepsy in Iran.

Factors associated with incidence and prevalence {#sec3.2}
------------------------------------------------

Age {#sec3.3}
---

Age-specific incidence of epilepsy has been indicated to be higher in young children and the elderly, while its incidence rate is lower in young and middle-aged adults ([Table I](#t0001){ref-type="table"}). Although current studies are not in perfect concordance, it has been reported that epilepsy increases in older age (over 65 years of age) and among people of Asian descent \[[@cit0015]\].

In developed countries, most previous investigations reported that the prevalence of epilepsy increased with age after 50 \[[@cit0020], [@cit0021]\]. A meta-analysis study estimated that the epilepsy recurrence rate based on age was 0.05 in people under 20 years and 0.04 in those over 20 years of age \[[@cit0019]\]. There is a general trend towards high prevalence of epilepsy among people in adolescence or early adulthood groups \[[@cit0021], [@cit0022]\]. Some studies have reported higher rates of epilepsy for people under 20 years old in Iran \[[@cit0022]--[@cit0024]\], while other studies found higher rates of disease in people aged over 20 years \[[@cit0017], [@cit0018], [@cit0025], [@cit0026]\].

Gender {#sec3.4}
------

Males have a slightly higher risk as of developing epilepsy as compared to females \[[@cit0027], [@cit0028]\]*.* However, the overall difference is negligible. A meta-analysis and systematic review reported that prevalence of epilepsy did not show a significant gender difference in Iran \[[@cit0019], [@cit0029]\]. Moreover, a similar pattern was seen in Pakistan and India \[[@cit0029]\]. However, another investigation reported that epilepsy was more common in females as compared to males \[[@cit0017]\]. The prevalence of epilepsy based on gender in southern Iran is not markedly different from the worldwide figure \[[@cit0030]\]. Despite the narrowing of gender differentials in the world, the prevalence and incidence of epilepsy require further investigations in Iran and cannot be interpreted with certainty without epidemiological studies ([Table I](#t0001){ref-type="table"}).

Residential areas {#sec3.5}
-----------------

A cross-sectional nationwide epidemiological study indicated that the prevalence of epilepsy was not markedly correlated with the residential areas \[[@cit0017]\]. It cannot be interpreted whether residential areas are associated with high prevalence of epilepsy in Iran, due to limited information. However, the lack of facilities and limited services in rural areas may be influential in this matter.

Socioeconomic status {#sec3.6}
--------------------

Socioeconomic factors such as infections, poor hygiene, and poor health-seeking behavior and poor nutrition increase the risk of epilepsy and its outcome. There have been few relevant studies in Iran. The prevalence of epilepsy appears to be associated with socioeconomic status in the lower socioeconomic groups \[[@cit0012]\]. Among the few investigations, socioeconomic factors were rarely evaluated for such correlations in Iran. An epidemiological study of the Iranian population conducted by Mohammadi *et al.* \[[@cit0017]\] indicated that occupational status may be related to epilepsy in males. They suggested that unemployed, the most common occupation status, was correlated with the disease, in agreement with previous studies worldwide \[[@cit0031]--[@cit0033]\]. In contrast to previous studies, epilepsy was found to be linked to poor academic level \[[@cit0026], [@cit0034], [@cit0035]\].

Mohammadi *et al.* \[[@cit0017]\] reported that epilepsy was more common at a higher educational level compared with the lower ones. On the other hand, statistically significant associations were reported between epilepsy and psychological needs, gender, employment status, education level, marital status and number of family members \[[@cit0036]\]. A previous study in Iran indicated that marital status was not correlated with epilepsy, while some prior studies have found a lower rate of marriage in patients with epilepsy worldwide \[[@cit0032]\]. Moreover, it has been shown that marital status and number of children had no effect on quality of life, while educational level, occupation and income did influence quality of life \[[@cit0037]\]. Worldwide, it has been shown that low socioeconomic status, low income, and less education are associated with epilepsy, and these factors have effects on hospitalization, drug-related side effects, and uncontrolled seizures \[[@cit0034], [@cit0035]\].

General attitudes toward epilepsy in Iran {#sec3.7}
-----------------------------------------

In a comprehensive study, Masoudnia \[[@cit0038]\] evaluated Iranian awareness, understanding and attitudes towards epilepsy among five major Iranian ethnic groups, i.e. Persian, Azeri, Kurd, Lur, and Arab. He found that the level of awareness about epilepsy was acceptable. Moreover, most of them believed physical causes of epilepsy and rejected metaphysical causes. Iranian people had a positive attitude about their child's employment and childbearing, but their attitude regarding children's marriage with a person with epilepsy were highly negative, while attitudes about the treatment of epilepsy were desirable.

Ghanean *et al.* \[[@cit0039]\] suggested that the awareness and attitudes towards epilepsy are more or less similar to those in Europe, but their attitudes regarding children's marriage with epilepsy patients were much lower. Another study in western Iran reported that there is acceptable awareness and positive attitudes about epilepsy among schoolteachers \[[@cit0040]\]. Another study in Fars province of Iran reported that more than two-thirds of the biology teachers had a positive attitude to epilepsy, while the remainder had misconceptions and negative attitudes toward epilepsy \[[@cit0041]\]. The perception of epilepsy seems to be relatively good, because modern treatment has considerably decreased its medical and social consequences.

Quality of life (QOL) of epileptic patients {#sec3.8}
-------------------------------------------

Epilepsy influences QOL in patients and epileptic patients have lower QOL compared with that in patients with other chronic diseases and normal people \[[@cit0042]--[@cit0044]\]. As previously shown in the literature, psychological and social issues are linked to epilepsy including self-image, socioeconomic status, insurance issues, and stigma. However, epilepsy has an important role for the patient, family, and society. Management of seizures and lifestyle have key roles for epilepsy therapy. Age, duration of the disease, and frequency and severity of seizures are negatively correlated with QOL. Moreover, type of epilepsy is associated with the opinion of people about their QOL.

In patients with epilepsy, self-management can help individuals to improve seizure control and well-being \[[@cit0045]\]. Various training programs have been conducted regarding epileptic patients in Iran. Training programs for patients and parents of epileptic children are markedly effective for self-management \[[@cit0046]\]. Current evidence indicates their direct association with patient satisfaction and self-management \[[@cit0047]\]. Various studies have evaluated the QOL of epileptic patients worldwide. In a comprehensive study in Iran and Persian Gulf countries, differences were found in the QOL compared with participants in Europe. Moreover, they indicated that epileptic patients had low quality of life in aspects including physical, social and energy \[[@cit0048]\]. Darabi *et al.*, in a cross-sectional study, found that seizure frequency and education are markedly associated with QOL in patients with epilepsy. They concluded that reducing seizure frequency and identification of intervening factors with education are required for improvement of QOL in patients with epilepsy \[[@cit0049]\].

Javaheri *et al.* in Iran showed the effectiveness of cognitive-behavioral stress management (CBSM) group education for QOL in females with temporal lobe epilepsy. They suggested that improving patients' physical, mental, and social conditions is correlated with quality of life in patients \[[@cit0050]\]. Aliasgharpour *et al.* in 2013 suggested that the educational program is beneficially effective for self-management behaviors in patients with epilepsy in Zanjan province, Iran. This indicates that an educational program must become an important service in epilepsy care \[[@cit0051]\].

It has been shown that incidence of epilepsy was high in childhood and adolescence and formation of personality can be developed in this period. Adolescents with epilepsy, with comorbid conditions, had lower QOL \[[@cit0052], [@cit0053]\]. Another study in Iran showed an unsatisfactory state of the QOL of adolescents with epilepsy as compared to other studies. This study suggested serious concern regarding the psychological status and risk factors for the QOL of adolescents with epilepsy in Iran. It was found that stigma in adolescents with epilepsy was higher compared with that in other countries, and QOL was lower in the patients. It has been reported that adolescents with epilepsy on monotherapy have better QOL \[[@cit0054]\]. Rajabi *et al.* reported that good effects of antiepileptic drugs were correlated with the QOL of those on polytherapy \[[@cit0037]\]. Successful self-management of chronic diseases requires appropriate educational support for effective self-management. Self-management training programs can be used for improving the skills and self-sufficiency, and patients should be informed on management and treatment of epilepsy. Demographic characteristics, socio-economic factors and clinical presentation are linked to different QOL of these patients among nations. Self-management training programs must be based on the learners' specific characteristics including sex, age, culture, educational level, residential place, etc. \[[@cit0047], [@cit0055]--[@cit0060]\].

In conclusion, the point prevalence of epilepsy has been estimated to be between 2.1 and 4 per 1000 individuals in Iran. The overall prevalence of epilepsy in Iran was calculated to be about 5% \[[@cit0019]\]. The prevalence of epilepsy appears to be correlated with socioeconomic status in the lower socioeconomic groups. A statistically significant association has been found between epilepsy and psychological needs, gender, employment status, education level, marital status and number of family members. It has been suggested that the awareness and attitudes towards epilepsy and treatment are acceptable, but attitudes regarding children's marriage with epileptic patients were much lower. The psychological and social issues are linked to epilepsy including self-image, socioeconomic status, insurance issues, and stigma. In patients with epilepsy, self-management can help individuals to improve seizure control and well-being. Epileptic patients had low quality of life in aspects including physical, social and energy.

Demographic characteristics, socio-economic factors and clinical presentation are linked to different QOL of these patients among nations. The educational program is beneficially effective for self-management behaviors in patients with epilepsy. Self-management training programs can be used for improving the skills and self-sufficiency, and patients should be informed on management and treatment of epilepsy. However, better data sources, a good recording system, and new techniques are needed to identify epidemiology of epilepsy. Available data are limited to published investigations in Iran. Other non-published data and comprehensive studies are required for better evaluation of the situation of epilepsy in Iran.
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